NCT05968430

Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2023-07-14Est. Completion: 2025-12-30

Enrollment target: 1,076 participants

Locations

Accel Research Sites (ARS) - Birmingham Clinical Research Unit, Birmingham, Alabama, United States
G & L Research LLC, Foley, Alabama, United States
Chandler Clinical Trials, Chandler, Arizona, United States
Arizona Kidney, Glendale, Arizona, United States
AKDHC Medical Research Services, AZ, Phoenix, Arizona, United States
Noble Clinical Research, Tucson, Arizona, United States
Del Sol Research Management, LLC, Tucson, Arizona, United States
Entertainment Medical Group, Inc, Beverly Hills, California, United States
CA Institute of Renal Research, CA, Chula Vista, California, United States
Amicis Research Center - Vacaville, Fairfield, California, United States
Amicis Research Center - Granada Hills, Granada Hills, California, United States
Marvel Clinical Research 002, LLC, Huntington Beach, California, United States
University of California San Diego (UCSD) - Altman Clinical and Translational Research Institute (ACTRI), La Jolla, California, United States
Clinical Trials Research (CTR) - Lincoln, Lincoln, California, United States

Uncontrolled Hypertension

The purpose of this clinical investigation (NCT01679132) is to assess the long-term safety and efficacy of the BAROSTIM …

Phoenix, United StatesCompleted Jul 2025

GlaucomaGlaucoma, Suspect

Goldmann Applanation Tonometry (GAT) is considered the clinical gold standard for eye pressure measurements and yet it i…

Durham, United StatesCompleted May 31, 2024

Infertility

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.